Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 470,166 | 198,911 | 138,838 | 174,935 | 102,055 |
| Receivables | 225,532 | 275,296 | 265,737 | 251,799 | 148,186 |
| Inventories | 310,117 | 316,054 | 280,347 | 296,332 | 217,263 |
| Other current assets | 162,105 | 0 | 0 | 0 | 0 |
| TOTAL | $1,237,202 | $858,168 | $775,082 | $822,146 | $495,170 |
| Non-Current Assets | |||||
| PPE Net | 287,529 | 337,404 | 300,112 | 269,251 | 222,369 |
| Intangibles | 1,921,803 | 1,985,871 | 2,005,971 | 2,097,532 | 1,071,746 |
| Other Non-Current Assets | 168,602 | 121,797 | 26,722 | 22,328 | 18,669 |
| TOTAL | $2,377,934 | $2,445,072 | $2,332,805 | $2,389,111 | $1,312,784 |
| Total Assets | $3,615,136 | $3,303,240 | $3,107,887 | $3,211,257 | $1,807,954 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 112,500 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 54,608 | 113,090 | 76,050 | 93,967 | 29,057 |
| Accrued Expenses | 170,311 | 156,194 | 160,238 | 161,100 | 87,732 |
| Other current liabilities | 17,026 | 4,772 | 3,764 | 22,793 | N/A |
| TOTAL | $401,013 | $331,309 | $262,552 | $348,911 | $123,601 |
| Non-Current Liabilities | |||||
| Long Term Debt | 933,387 | 1,303,061 | 1,210,513 | 1,781,142 | 665,000 |
| Deferred Revenues | N/A | N/A | N/A | 11,051 | 6,812 |
| Other Non-Current Liabilities | 749,679 | 215,581 | 201,248 | 53,768 | 30,745 |
| TOTAL | $1,699,256 | $1,555,195 | $1,469,539 | $1,900,040 | $844,686 |
| Total Liabilities | $2,100,269 | $1,886,504 | $1,732,091 | $2,248,951 | $968,287 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,370 | 84,443 | 85,229 | 78,494 | 74,816 |
| Common Shares | 893 | 887 | 880 | 813 | 777 |
| Retained earnings | 532,265 | 398,574 | 348,373 | 285,186 | 220,443 |
| Other shareholders' equity | -74,200 | -76,345 | -45,058 | -23,451 | -57,205 |
| TOTAL | $1,514,867 | $1,416,736 | $1,375,796 | $962,306 | $839,667 |
| Total Liabilities And Equity | $3,615,136 | $3,303,240 | $3,107,887 | $3,211,257 | $1,807,954 |